99 related articles for article (PubMed ID: 2116668)
1. Mitomycin, ifosfamide, and mesna in the treatment of lung cancer.
Dorr RT
Semin Oncol; 1990 Aug; 17(4 Suppl 7):2-5. PubMed ID: 2116668
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy with ifosfamide, mitomycin, and cisplatin in advanced non-small cell lung cancer.
Girón CG; Ordónez A; Jalón JI; Barón MG
Cancer Treat Rep; 1987 Sep; 71(9):851-3. PubMed ID: 3040245
[TBL] [Abstract][Full Text] [Related]
3. An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer.
Depierre A; Milleron B; Lebeau B; Moro D; Chastang C; Jacoulet P; Paillot N; Quoix E; Janicot H; Lombard JN
Semin Oncol; 1994 Jun; 21(3 Suppl 4):16-9. PubMed ID: 8209272
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with adriamycin, ifosfamide and mesna in extensive-stage non-small cell bronchogenic carcinoma.
Matthiessen W; Stempinski E; Göbel D; Thalmann U
Cancer Treat Rev; 1983 Sep; 10 Suppl A():121-3. PubMed ID: 6414688
[No Abstract] [Full Text] [Related]
5. [Polychemotherapy of non-small cell bronchial cancer with mitomycin C, ifosfamide and vindesine].
Laumen R; Jungbluth H; von Pawel J; Häussinger K; Otto M; Krieger H
Pneumologie; 1990 Feb; 44 Suppl 1():590. PubMed ID: 2164206
[TBL] [Abstract][Full Text] [Related]
6. Mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer.
Soh LT; Tan EH; Ang PT
Singapore Med J; 1998 Aug; 39(8):357-8. PubMed ID: 9844496
[TBL] [Abstract][Full Text] [Related]
7. Experience with 24-h infusions of ifosfamide/mesna in small cell lung cancer.
Cantwell BM; Harris AL; Bozzino JM
Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S29. PubMed ID: 3028660
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy of advanced non-small cell bronchial cancer with mitomycin C/ifosfamide versus mitomycin C/vindesine versus cisplatin/etoposide--a prospective randomized study].
Gatzemeier U; Heckmayr M; Hossfeld DK; Kaukel E; Koschel G; Neuhauss R
Pneumologie; 1990 Feb; 44 Suppl 1():258-60. PubMed ID: 2164194
[TBL] [Abstract][Full Text] [Related]
9. Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.
You B; Tranchand B; Girard P; Falandry C; Ribba B; Chabaud S; Souquet PJ; Court-Fortune I; Trillet-Lenoir V; Fournel C; Tod M; Freyer G
Lung Cancer; 2008 Nov; 62(2):261-72. PubMed ID: 18442869
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of mitomycin/ifosfamide/cisplatin preoperative chemotherapy plus surgery versus surgery alone in stage IIIA non-small cell lung cancer.
Rosell R; Maestre J; Font A; Moreno I; Molina F; Milla A; Gómez-Codina J; Camps C
Semin Oncol; 1994 Jun; 21(3 Suppl 4):28-33. PubMed ID: 8209274
[TBL] [Abstract][Full Text] [Related]
11. Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.
Hoffman PC; Masters GA; Drinkard LC; Krauss SA; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Jun; 23(3 Suppl 6):11-5. PubMed ID: 8677441
[TBL] [Abstract][Full Text] [Related]
12. Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
Semin Oncol; 1989 Feb; 16(1 Suppl 3):68-72. PubMed ID: 2539647
[TBL] [Abstract][Full Text] [Related]
13. Anticipated administration of GM-CSF in the treatment of non small cell lung cancer.
Erkisi M; Erkurt E; Zeren H; Tunali C; Kocabas A; Burgut R
J Exp Clin Cancer Res; 2001 Sep; 20(3):345-9. PubMed ID: 11718213
[TBL] [Abstract][Full Text] [Related]
14. High-dose ifosfamide and mesna in advanced breast cancer. A phase II study.
Sanchiz F; Milla A
Cancer Chemother Pharmacol; 1990; 26 Suppl():S91-2. PubMed ID: 2112057
[TBL] [Abstract][Full Text] [Related]
15. Ifosfamide in non-small cell lung cancer.
Johnson DH
Semin Oncol; 1996 Jun; 23(3 Suppl 6):7-10. PubMed ID: 8677453
[TBL] [Abstract][Full Text] [Related]
16. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
[TBL] [Abstract][Full Text] [Related]
17. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P
Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
[TBL] [Abstract][Full Text] [Related]
18. Irreversible encephalopathy with ifosfamide/mesna.
Salloum E; Flamant F; Ghosn M; Taleb N; Akatchereian C
J Clin Oncol; 1987 Aug; 5(8):1303-4. PubMed ID: 3114437
[No Abstract] [Full Text] [Related]
19. [Combination chemotherapy with VP-16 in the treatment of lung cancer and malignant lymphoma].
Hosomi Y; Shibuya M
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1352-6. PubMed ID: 11681241
[TBL] [Abstract][Full Text] [Related]
20. Ifosfamide, mesna and vincristine in paediatric oncology.
de Kraker J; Voûte PA
Cancer Treat Rev; 1983 Sep; 10 Suppl A():165-6. PubMed ID: 6414690
[No Abstract] [Full Text] [Related]
[Next] [New Search]
